Thus, GFR, alkaline phosphatase, and albumin were detected in this study to reflect renal and liver functions in patients with high-risk prostate cancer who received Boennuokang® leuprorelin acetate microspheres-based treatment as neoadjuvant therapy. Here, ALB is linked to prostate carcinoma.